symptoms of semaglutide overdose FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products The Boom in New Weight

Supports Liver and Gut Health - Milk thistle and DIM aid liver detox pathways and help manage glucose metabolism and uptake

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Semaglutide is a powerful GLP-1 medication, but certain drug combinations require careful monitoring

It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

While a number of mechanisms including vascular, myocardial, renal, and central nervous system pathways have been suggested in animal studies, these mechanistic pathways have not been sufficiently detailed in humans and it is unclear if the same pathways are operational